Eden granted US EPA regulatory approval

26 September 2022

The US EPA has granted Eden Research regulatory approval for or all five petitions submitted, covering the Company's three active ingredients (eugenol, geraniol and thymol) and two formulated products (Mevalone ® and Cedroz ™). The EPA approval of Eden's products and active ingredients will open significant revenue opportunities for Eden, with a total market potential of approximately €94m for Mevalone and €189m for Cedroz.

For further information, follow this link.

← Read other news articles